BeiGene vs CureVac
BeiGene vs CureVac, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and CureVac on 40/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 40/100
- agent readiness: 50/100 against 38/100
CureVac
- funding raised: $2.1B against $358M
At a glance
| Measure | BeiGene | CureVac |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2010 | 2000 |
| Headquarters | Cambridge, United States | Tübingen, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | CureVac |
|---|---|---|
| Open roles | 100 | Not published |
| Total funding | $358M | $2.1B |
| Latest round | Secondary Offering | IPO |
| Valuation | $15B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | CureVac |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 40/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | Not published |
| Search visibility | 17/100 | 3/100 |
| Quality | 88/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (38/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | CureVac |
|---|---|---|
| Hosting | Not detected | Hetzner |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
BeiGene vs CureVac: common questions
Which is better, BeiGene or CureVac?
On our 0-100 score BeiGene rates higher (64/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do BeiGene and CureVac compare on the numbers?
BeiGene leads on our overall score (64/100 against 40/100), agent readiness (50/100 against 38/100). CureVac leads on funding raised ($2.1B against $358M).
Read the full BeiGene review and pricing or the CureVac review and pricing. You can also browse other BeiGene alternatives we track.